The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Eastman Chemical's revenues will increase 29.2% and EPS will expand 17.1%.
The average estimate for revenue is $2.39 billion. On the bottom line, the average EPS estimate is $1.64.
Last quarter, Eastman Chemical logged revenue of $2.31 billion. GAAP reported sales were 27% higher than the prior-year quarter's $1.82 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.62. GAAP EPS of $1.57 for Q1 were 40% higher than the prior-year quarter's $1.12 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 26.7%, 300 basis points better than the prior-year quarter. Operating margin was 17.5%, 250 basis points better than the prior-year quarter. Net margin was 10.7%, 200 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $9.40 billion. The average EPS estimate is $6.34.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 194 members out of 220 rating the stock outperform, and 26 members rating it underperform. Among 70 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 66 give Eastman Chemical a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Eastman Chemical is outperform, with an average price target of $80.33.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Eastman Chemical to My Watchlist.